Medtronic Receives IDE Approval to Initiate Study of IN.PACT Admiral Drug-Coated Balloon
Medtronic plc (MDT) announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the IN.PACT Admiral…
Read More...
Read More...